Interleukin 4 in Systemic Sclerosis: Not Just an Increase
AUTOR(ES)
Atamas, Sergei P.
FONTE
American Society for Microbiology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=95749Documentos Relacionados
- Lymphocyte cytotoxicity in systemic sclerosis: no increase on short-term culture with established human cell lines.
- Serological markers in progressive systemic sclerosis: clinical correlations.
- Systemic sclerosis: is there a treatment yet?
- Autonomic dysfunction in systemic sclerosis: the site of damage.
- A new promising treatment in systemic sclerosis: 5-fluorouracil.